CRDL
NASDAQ · Pharmaceuticals
Cardiol Therapeutics Inc-A
$1.05
+0.06 (+5.54%)
Open$0.99
Previous Close$0.99
Day High$1.08
Day Low$0.97
52W High$2.17
52W Low$1.09
Volume—
Avg Volume107.1K
Market Cap146.30M
P/E Ratio—
EPS$-0.42
SectorPharmaceuticals
Analyst Ratings
Strong Buy
8 analysts
Price Target
+2,212.4% upside
Current
$1.05
$1.05
Target
$24.28
$24.28
$16.80
$24.28 avg
$33.59
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 21.47M | 20.00M | 18.14M |
| Net Income | 5.10M | 5.20M | 4.96M |
| Profit Margin | 23.8% | 26.0% | 27.3% |
| EBITDA | 10.24M | 10.30M | 9.42M |
| Free Cash Flow | 5.58M | 6.38M | 6.16M |
| Rev Growth | +3.9% | -4.2% | -9.3% |
| Debt/Equity | 1.16 | 1.28 | 1.00 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $916.31 | +1.47% | 46.4 | 957.52B |
| JNJ | Johnson & Johnson | $239.93 | +1.98% | 22.2 | 594.00B |
| MRK | Merck & Co. Inc. | $119.37 | +2.58% | 16.5 | 301.17B |
| PFE | Pfizer Inc. | $27.28 | +1.19% | 19.7 | 153.36B |
| BMY | Bristol-Myers Squibb Co | $58.94 | +2.70% | 16.5 | 116.58B |
| ZTS | Zoetis Inc | $116.71 | +0.67% | 21.5 | 57.37B |